Article
The common D302H variant of CASP8 is associated with risk of glioma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Apr 2008
Bethke Lara, Sullivan Kate, Webb Emily, Murray Anne, Schoemaker Minouk, Auvinen Anssi, Kiuru Anne, Salminen Tiina, Johansen Christoffer, Christensen Helle Collatz, Muir Kenneth, McKinney Patricia, Hepworth Sarah, Dimitropoulou Polyxeni, Lophatananon Artitaya, Feychting Maria, Lönn Stefan, Ahlbom Anders, Malmer Beatrice, Henriksson Roger, Swerdlow Anthony, Houlston Richard
Abstract excerpt
Caspase 8 (CASP8) is a key regulator of apoptosis or programmed cell death, and, hence, a defense against cancer. We tested the hypothesis that the CASP8 polymorphism D302H influences risk of glioma through analysis of five series of glioma case patients and controls (n = 1,005 and 1,011, respectively). Carrier status for the rare allele of D302H was associated with a 1.37-fold increased risk (95% confidence...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
